Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Stem Cell Culture01:17

Stem Cell Culture

5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainable soil improvement strategies for coral islands: Synergistic application of sludge/carboxymethyl cellulose-derived hydrogel and biochar.

International journal of biological macromolecules·2026
Same author

Association between statin use and dry eye disease: A systematic review and meta-analysis.

American journal of ophthalmology·2026
Same author

Oxygen-generating Microparticles Enhance Viability and Functionality of Human Pluripotent Stem Cell-derived Cardiomyocytes for Myocardial Infarction Therapy.

Stem cell reviews and reports·2026
Same author

Binaural Processing Is Key to Tonal-Language Benefits and Right-Ear Advantage for Segregation of Competing Speech.

Journal of speech, language, and hearing research : JSLHR·2026
Same author

<i>In vivo</i> CRISPR-mediated activation of cardiogenic genes to reprogram cardiac fibroblasts.

Frontiers in cell and developmental biology·2026
Same author

Co-inoculation of arbuscular mycorrhizal fungi and rhizobia reshapes microbial ecology and nutrient metabolism to rehabilitate iron ore tailings.

Environmental research·2026
Same journal

Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

Canadian journal of physiology and pharmacology·2026
Same journal

Exploring the causal relationship between inflammatory cytokines and diabetic foot ulcer: A bidirectional Mendelian randomization and clinical validation study.

Canadian journal of physiology and pharmacology·2026
Same journal

TRPV1, Endocannabinoid, and Opioid Systems in Analgesia: Molecular Mechanisms and Drug Development Strategies.

Canadian journal of physiology and pharmacology·2026
Same journal

Association of stromal cell derived factor 1α and interferon-γ induced protein 10 with Fontan pathophysiology.

Canadian journal of physiology and pharmacology·2026
Same journal

Incretins for Type 2 Diabetes.

Canadian journal of physiology and pharmacology·2026
Same journal

Glucagon-like peptide 1 receptor agonists: anti-inflammatory effects in cardiovascular diseases.

Canadian journal of physiology and pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jul 12, 2025

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.5K

Direct cellular reprogramming techniques for cardiovascular regenerative therapeutics.

Xingyu He1, Suchandrima Dutta2, Jialiang Liang1

  • 1Department of Pathology & Laboratory MedicineCollege of Medicine, University of Cincinnati, Cincinnati, OH 45267-0529, USA.

Canadian Journal of Physiology and Pharmacology
|October 30, 2023
PubMed
Summary
This summary is machine-generated.

Direct reprogramming converts somatic cells to cardiac cells, offering a promising regenerative medicine approach for heart failure. This method bypasses pluripotent cells, reducing risks and enhancing therapeutic potential for cardiovascular diseases.

Keywords:
cardiovascular diseasesregenerative medicinereprogrammingtranscription factors

More Related Videos

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.3K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

8.7K

Related Experiment Videos

Last Updated: Jul 12, 2025

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.5K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.3K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

8.7K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Cellular Reprogramming

Background:

  • Cardiovascular diseases cause significant global hospitalizations, with current treatments unable to reverse myocardial infarction or heart failure.
  • Direct reprogramming offers a novel strategy to generate cardiomyocytes and cardiac progenitor cells from somatic cells.

Purpose of the Study:

  • To review the evolution and recent advancements in direct reprogramming for cardiac cell fate conversion.
  • To explore the molecular mechanisms underlying direct cardiac reprogramming.
  • To discuss delivery methods and challenges in translational cardiac regenerative therapeutics.

Main Methods:

  • Overexpression of key transcription factors (e.g., GATA4, MEF2C, TBX5) to initiate direct reprogramming.
  • Utilizing combinations of transcription factors, microRNAs, and small molecules to enhance reprogramming efficiency.
  • Investigating various viral and non-viral delivery systems for reprogramming factors.

Main Results:

  • Direct reprogramming can bypass the pluripotent stage, potentially yielding non-immunogenic and less carcinogenic cell products.
  • Significant progress has been made in improving the efficiency of cardiac cell fate conversion through refined reprogramming protocols.
  • Understanding of molecular reprogramming mechanisms has advanced, alongside exploration of effective delivery strategies.

Conclusions:

  • Direct reprogramming represents a promising avenue for cardiac regeneration, offering advantages over traditional stem cell therapies.
  • Overcoming molecular and epigenetic barriers is crucial for the successful translation of direct reprogramming into clinical therapies for heart failure.
  • Continued research is essential to fully realize the potential of direct reprogramming in treating cardiovascular diseases.